FERMT2 and triple-negative breast carcinoma: <h4>Background</h4>Kindlin-2, an adaptor protein, is dysregulated in various human cancers, including triple negative breast cancer (TNBC), where it drives tumor progression and metastasis by influencing several cancer hallmarks.